HIPRA has appointed Carles Pascual and Montse Montaner as new members of its Board of Directors, a strategic move aligned with the company’s ambition to propel a new stage of transformation and growth. With these appointments, HIPRA reinforces its governance structure and consolidates a more robust, diverse, and independent Board, well equipped to support the company’s development in a highly demanding global landscape.

This step reflects HIPRA’s commitment to a solid governance model aligned with international standards and underscores the company’s capacity to transform, grow, and generate sustainable value. The addition of top-level executive talent will contribute to strengthening HIPRA’s strategic direction and ensuring continuity in a corporate trajectory built on trust, responsibility, and good governance.

Carles Pascual: international experience in corporate leadership and global expansion

Carles Pascual, who holds a degree in Law from the University of Barcelona and an MBA from ESADE, has built a career spanning more than three decades at Werfen, where he has held senior leadership positions and played a key role in the company’s international expansion and in its consolidation as one of the world’s leading in vitro diagnostics firms. Pascual has worked closely with the Board of Directors and the ownership, helping to define corporate strategy and uphold the company’s founding values.

Montse Montaner: global leadership in quality, sustainability, and pharmaceutical operations

Montse Montaner, a graduate in Pharmacy from the University of Barcelona, where she has also been a lecturer, and trained in executive programmes at Harvard Business School and IESE, brings over 25 years of experience in the international pharmaceutical industry, where she has held senior leadership roles at companies such as Novartis and Sanofi. Her expertise in quality, regulatory compliance, and risk management has led her to oversee quality operations across manufacturing sites, technical laboratories, and third-party networks, with experience spanning a wide range of therapeutic areas.